Todd W. Rockway

1.3k citations

38 papers · 940 indexed · h-index 20

Co-authors: Vincent L. Giranda V. Nienaber Stephen W. Fesik Robert T. Gampe Kent D. Stewart Moshe Weitzberg Victor J. Hruby Wood Yee Chan
Topics: Protease and Inhibitor Mechanisms (9 papers)Peptidase Inhibition and Analysis (8 papers)HIV/AIDS drug development and treatment (8 papers)
Cited by: Hepatology Cancer Research Organic Chemistry
Journals: Biochemistry Biochemical and Biophysical Research Communications Journal of Medicinal Chemistry
Partner nations: United States United Kingdom Poland

In The Last Decade

Todd W. Rockway

37 papers receiving 877 citations

Peers

Countries citing papers authored by Todd W. Rockway

Since Specialization

Citations

This map shows the geographic impact of Todd W. Rockway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd W. Rockway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd W. Rockway more than expected).

Fields of papers citing papers by Todd W. Rockway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd W. Rockway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd W. Rockway. The network helps show where Todd W. Rockway may publish in the future.

Co-authorship network of co-authors of Todd W. Rockway

This figure shows the co-authorship network connecting the top 25 collaborators of Todd W. Rockway. A scholar is included among the top collaborators of Todd W. Rockway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd W. Rockway. Todd W. Rockway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of fluorobenzimidazole HCV NS5A inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·John T. Randolph,Charles A. Flentge,(unknown),Todd W. Rockway,(unknown),Lissa T.J. Nelson,Douglas K. Hutchinson,Rubina Mondal,(unknown),Thomas Reisch,Tatyana Dekhtyar,Preethi Krishnan,Edward Tam,DeAnne Stolarik,David W. A. Beno,Rolf Wagner,Clarence J. Maring,Warren M. Kati	4
2	Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Daniel P. Larson,Rolf Wagner,(unknown),Todd W. Rockway,Warren M. Kati,Yaya Liu,Sherie Masse,Tim Middleton,Hongmei Mo,Debra Montgomery,Wen Jiang,Gennadiy Koev,Dale J. Kempf,Akhter Molla	16
3	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring 2006 ·Bioorganic & Medicinal Chemistry Letters ·Todd W. Rockway,Rong Zhang,Dachun Liu,David A. Betebenner,Keith F. McDaniel,John K. Pratt,David W. A. Beno,Debra Montgomery,(unknown),Sherie Masse,Warren M. Kati,Tim Middleton,Akhteruzzaman Molla,Clarence J. Maring,Dale J. Kempf	22
4	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides 2006 ·Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger,Darold L. Madigan,Wen Jiang,Warren M. Kati,Dachun Liu,Yaya Liu,Clarence J. Maring,Sherie Masse,Keith F. McDaniel,Tim Middleton,Hongmei Mo,Akhteruzzaman Molla,Debra Montgomery,John K. Pratt,Todd W. Rockway,Rong Zhang,Dale J. Kempf	24
5	Interaction with the S1β-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Michael Wendt,(unknown),William J. McClellan,Todd W. Rockway,Moshe Weitzberg,(unknown),Robert A. Mantei,Kent D. Stewart,V. Nienaber,Vered Klinghofer,Vincent L. Giranda	24
6	Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties 2004 ·Bioorganic & Medicinal Chemistry Letters ·Milan Bruncko,William J. McClellan,Michael Wendt,Daryl R. Sauer,(unknown),(unknown),(unknown),Moshe Weitzberg,(unknown),Joseph F. Dellaria,Robert A. Mantei,(unknown),V. Nienaber,Kent D. Stewart,Vered Klinghofer,Jennifer B. Bouska,Todd W. Rockway,Vincent L. Giranda	19
7	Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles 2004 ·Antiviral Research ·Timothy Middleton,(unknown),Debra Montgomery,Todd W. Rockway,Haolin Tang,Xueheng Cheng,Liangjun Lu,Hongmei Mo,W E Kohlbrenner,Abul Hossain Molla	22
8	Pyridone-Containing farnesyltransferase inhibitors: synthesis and biological evaluation 2003 ·Bioorganic & Medicinal Chemistry Letters ·Lisa Hasvold,Weibo Wang,Stephen L. Gwaltney,Todd W. Rockway,Lissa T.J. Nelson,Robert A. Mantei,Stephen A. Fakhoury,Gerard M. Sullivan,Qun Li,Nan‐Horng Lin,(unknown),Haiying Zhang,Jerome Cohen,Wen‐Zhen Gu,Kennan C. Marsh,Joy Bauch,Saul H. Rosenberg,Hing L. Sham	64
9	Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator 2003 ·Current Pharmaceutical Design ·Todd W. Rockway,Vincent L. Giranda	34
10	Inhibitors of the Protease Domain of Urokinase-Type Plasminogen Activator 2002 ·Current Pharmaceutical Design ·Todd W. Rockway,V. Nienaber,Vincent L. Giranda	49
11	Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite 2000 ·Structure ·V. Nienaber,Donald J. Davidson,Rohinton Edalji,Vincent L. Giranda,Vered Klinghofer,Jack Henkin,(unknown),Robert A. Mantei,(unknown),Jean M. Severin,Richard A. Smith,Kent D. Stewart,Karl A. Walter,Jieyi Wang,Michael Wendt,Moshe Weitzberg,(unknown),Todd W. Rockway	46
12	An Efficient Process for the Synthesis of Renin Inhibitor, ABT-517 1996 ·Synthetic Communications ·(unknown),Curt W. Bradshaw,(unknown),B. A. Narayanan,Todd W. Rockway,(unknown),(unknown)	2
13	Truncated atrial natriuretic factor analogs retain full agonist activity 1991 ·Canadian Journal of Physiology and Pharmacology ·William H. Holleman,Gerald P. Budzik,(unknown),David M. Pollock,T. J. Opgenorth,(unknown),Thomas W von Geldern,Todd W. Rockway	3
14	Effects of conformational constraint in 2- and 8-cycloleucine analogues of oxytocin and [1-penicillamine] oxytocin examined by circular dichroism and biosassay 1990 ·Journal of Protein Chemistry ·I. Frič,Jan Hlaváček,Todd W. Rockway,Wood Yee Chan,Victor J. Hruby	7
15	Atrial natriuretic peptide antagonists: biological evaluation and structural correlations. 1990 ·Molecular Pharmacology ·Thomas W von Geldern,Gerald P. Budzik,(unknown),William H. Holleman,Mikael Holst,Yasuo Kiso,Eugene I. Novosad,T. J. Opgenorth,Todd W. Rockway,Alexandra M. Thomas	33
16	NMR study of the solution conformation of rat atrial natriuretic factor (7-23) in sodium dodecyl sulfate micelles 1988 ·Biochemistry ·Edward T. Olejniczak,Robert T. Gampe,Todd W. Rockway,Stephen W. Fesik	24
17	Two‐Dimensional NMR studies of [Pro‐10] atrial natriuretic factor [7‐23] 1988 ·Biopolymers ·Robert T. Gampe,Peter J. Connolly,Todd W. Rockway,Stephen W. Fesik	13
18	Application of isotope-filtered 2D NOE experiments in the conformational analysis of atrial natriuretic factor(7–23) 1987 ·Journal of Magnetic Resonance (1969) ·Stephen W. Fesik,Robert T. Gampe,Todd W. Rockway	43
19	Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: Evidence for receptor subtypes 1987 ·Biochemical and Biophysical Research Communications ·Gerald P. Budzik,Susan Firestone,Eugene N. Bush,Peter J. Connolly,Todd W. Rockway,Virender K. Sarin,William H. Holleman	43
20	Mo NMR spectra of Dioxomolybdenum(VI) complexes 1981 ·Inorganica Chimica Acta ·Kenner A. Christensen,Philip E. Miller,Martin Minelli,Todd W. Rockway,John H. Enemark	23

About Todd W. Rockway

Todd W. Rockway is a scholar working on Hepatology, Cancer Research and Infectious Diseases, having authored 38 papers that have together received 940 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), Peptidase Inhibition and Analysis (8 papers) and HIV/AIDS drug development and treatment (8 papers). The work is most often cited by research in Hepatology (162 citations), Cancer Research (182 citations) and Organic Chemistry (237 citations). Todd W. Rockway has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Vincent L. Giranda, V. Nienaber, Stephen W. Fesik, Robert T. Gampe, Kent D. Stewart, Moshe Weitzberg, Victor J. Hruby, Wood Yee Chan, Robert A. Mantei and Gerald P. Budzik. Their work appears in journals such as Biochemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact